Services

If you want to discuss a traditional diagnostic need - development, verification/validation, positioning, regulatory path (CLIA versus cleared/approved), etc. - let's chat. Through my network I can also assist with clinical trial design and conduct as well as statistical analyses and FDA filings.

For companion diagnostic services such as technology assessment/selection, partnering, biomarker/assay verification and validation, alignment with therapeutic clinical trials, etc.

With years of liquid biopsy (LBx) experience I can assist in the development and positioning of your specific assay, be that in the RUO, CLIA or clinical diagnostics space. Rare cells include circulating tumor cells (CTCs) for oncology applications and circulating fetal cells (CFTs) for NIPT (Non-Invasive Prenatal Testing).